Acetaminophen (APAP), a commonly used analgesic, is usually safe when administered at therapeutic doses. However, APAP overdose causes liver injury both in experimental animals and humans. APAP has been used extensively to develop an animal model of drug-induced liver injury. The toxicity is initiated by cytochrome P450 (CYP) metabolism into N-acetyl-p-benzoquinone imine (NAPQI), and the high reactivity of NAPQI with sulfhydryl groups results in depletion of reduced glutathione (GSH) in hepatocytes, followed by covalent binding to intracellular proteins.1-3) Therefore, hepatic GSH levels are important in protecting against APAP hepatotoxicity, and enhancement of hepatic GSH is a reasonable strategy for the treatment of APAP intoxication.N-Acetylcysteine (NAC) is clinically used as an antidote for APAP intoxication.4) It is thought that NAC provides cysteine (CYS) as a precursor of GSH which traps NAPQI, leading to a decrease in toxicity (Fig. 1). 5) However, NAC was shown to improve patient outcome after late administration 6) ; this could not be explained by trapping NAPQI. In fact, treatment of mice with NAC after APAP administration protected against hepatic necrosis without reducing covalent binding, suggesting that mechanisms other than GSH replenishment are involved in the hepatoprotective effects of NAC. [7][8][9] In contrast to NAC, GSH itself is not used as an antidote for APAP intoxication. It is believed that intraperitoneal administration of GSH is less effective in restoring hepatic GSH, probably because exogenous GSH can not be taken up by hepatocytes, whereas ethyl esters of GSH are proposed as GSH precursors that are taken up and hydrolyzed by hepatocytes into GSH (Fig. 1). 10) On the other hand, intravenously administered GSH was found to protect against APAP hepatotoxicity.11) It is considered that intravenous GSH rapidly degrades in the kidney, is absorbed as amino acids, and is used to synthesize GSH in the liver, which could led to hepatoprotection. These studies suggest the potential importance of restoring hepatic GSH levels in the protection against APAP hepatotoxicity by exogenous thiol compounds. The objective of this study was to clarify the role of GSH supplementation in the hepatoprotective action of NAC and other thiol compounds, which could lead to the development of a new hepatoprotective agent. We found that a relatively low dose of thiol compounds, GSH, NAC, CYS, and glutathione-monoethyl ester (GSH-EE), protected mice against APAP hepatotoxicity together with different abilities to re- An overdose of acetaminophen (APAP) causes liver injury both in experimental animals and humans. NAcetylcysteine (NAC) is clinically used as an antidote for APAP intoxication, and it is thought to act by providing cysteine as a precursor of glutathione, which traps a reactive metabolite of APAP. Other hepatoprotective mechanisms of NAC have also been suggested. Here, we examined the effects of thiol compounds with different abilities to restore hepatic glutathione, on hepatotoxicity of APAP and f...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.